Results 81 to 90 of about 3,181 (117)

Larva migrans cutanée bulleuse. [PDF]

CMAJ, 2023
Green R, Somayaji R, Chia JC.
europepmc   +1 more source

Éruptions papuleuses à zone atrophique centrale dite porcelainée et perforations intestinales à répétition chez une femme de 43 ans. [PDF]

CMAJ
Wiens J, Dunham M, Walker S, Au S.
europepmc   +1 more source

EMA approvals of new medicinal products and new biosimilar products in January and February 2025. [PDF]

Lancet Reg Health Eur
Burgos JG, Thirstrup S.
europepmc   +1 more source

[Neuromeningeal cryptococcosis in an HIV-negative patient with pulmonary tuberculosis in the Infectious and tropical diseases department of the University teaching hospital Point G of Bamako, Mali]. [PDF]

Med Trop Sante Int, 2022
Loua OO, Alle Akakpo AE, Ouedraogo D, Cissoko Y, Soumaré M, Konaté I, Dao S.   +6 more
europepmc   +1 more source

Total Metastases Volume and Relative Volume Reduction After Neoadjuvant Therapy Predict Outcome After Liver Resection of Colorectal Liver Metastases. [PDF]

Ann Surg Oncol
Lindenlaub F, Asenbaum U, Schwarz C, Makolli J, Mittlböck M, Stremitzer S, Kaczirek K.   +6 more
europepmc   +1 more source

Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance. [PDF]

Cancers (Basel), 2023
Bortolotti S, Angelucci S, Montemurro L, Bartolucci D, Raieli S, Lampis S, Amadesi C, Scardovi A, Nieddu G, Cerisoli L, Paganelli F, Chiarini F, Teti G, Falconi M, Pession A, Hrelia P, Tonelli R.   +16 more
europepmc   +1 more source

Recent developments in the delivery of peptide nucleic acids (PNAs). [PDF]

RSC Chem Biol
Sarkar S, Murthy N.
europepmc   +1 more source

Can Radionuclide Therapy be the Solution for Hepatitis B Virus Infection? [PDF]

Nucl Med Mol Imaging
Sung PS, Yoo IR.
europepmc   +1 more source

5-Substituted Flavones-Another Class of Potent Triplex DNA-Specific Ligands as Antigene Enhancers. [PDF]

Molecules
Gu L, Tran N, Rangel VM, Singh M, Christison KM, Lin-Cereghino GP, Xue L.   +6 more
europepmc   +1 more source

[Bispecific antibodies in prostate cancer therapy]. [PDF]

Urologie
Jung S, Heitmann J, Pflügler M, Jung G, Rausch S, Salih H.   +5 more
europepmc   +1 more source